Rafal Filip
Uniwersytet Rzeszowski
H-index: 25
Europe-Poland
Top articles of Rafal Filip
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
The Complex Relationship between Mechanisms Underlying Inflammatory Bowel Disease, Its Treatment, and the Risk of Lymphomas: A Comprehensive Review | Katarzyna Stasik Rafał Filip | 2024/4/11 | |
Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial | The Lancet Gastroenterology & Hepatology | Silvio Danese Remo Panaccione Brian G Feagan Anita Afzali David T Rubin | 2024/2/1 |
Modulation of the Gut Microbiota by Nutrition and Its Relationship to Epigenetics | Katarzyna Ferenc Aneta Sokal-Dembowska Kacper Helma Elżbieta Motyka Sara Jarmakiewicz-Czaja | 2024/1/19 | |
P1141 Global perspectives on managing Inflammatory Bowel Disease (IBD) during pregnancy and lactation: current state and the necessity for enhancements | MJ Casanova JP Gisbert A Amiot H Gordon G Fiorino | 2024/1/1 | |
Transplant of microbiota from Crohn’s disease patients to germ-free mice results in colitis | Gut Microbes | Irshad Ali Sheikh Jared Bianchi-Smak Daniel Laubitz Gabriele Schiro Monica T Midura-Kiela | 2024/12/31 |
Nutritional Support: The Use of Antioxidants in Inflammatory Bowel Disease | Sara Jarmakiewicz-Czaja Katarzyna Ferenc Aneta Sokal-Dembowska Rafał Filip | 2024/4/16 | |
P473 Corticosteroid-free clinical remission rates with guselkumab maintenance therapy in patients with moderately to severely active Crohn’s disease: Week 48 analyses from the … | Journal of Crohn's and Colitis | G D’Haens A Afzali R Filip A Rolim NA Terry | 2023/2/1 |
Tu1707 CORTICOSTEROID-FREE CLINICAL REMISSION RATES WITH GUSELKUMAB MAINTENANCE THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: WEEK 48 ANALYSES FROM … | Gastroenterology | Anita Afzali Geert D'Haens Rafal Filip Alexander Rolim Natalie A Terry | 2023/5/1 |
Tissue Metalloproteinases as Crohn Disease Recurrence Markers | Grzegorz Pasternak Grzegorz Chrzanowski David Aebisher Angelika Mysliwiec Klaudia Dynarowicz | 2023/8/8 | |
Crohn’s Disease: Basic Characteristics of the Disease, Diagnostic Methods, the Role of Biomarkers, and Analysis of Metalloproteinases: A Review | Grzegorz Pasternak Grzegorz Chrzanowski David Aebisher Angelika Myśliwiec Klaudia Dynarowicz | 2023/10/15 | |
P605 Real life efficacy of tofacitinib in different situation in ulcerative colitis: a retrospective worldwide multicentre collaborative study | Journal of Crohn's and Colitis | T Resál P Bacsur R Bor A Bálint K Katsanos | 2023/2/1 |
Antioxidants as protection against reactive oxidative stress in inflammatory bowel disease | Sara Jarmakiewicz-Czaja Katarzyna Ferenc Rafał Filip | 2023/4/18 | |
Real-life efficacy of tofacitinib in various situations in ulcerative colitis: a retrospective worldwide multicenter collaborative study | Inflammatory Bowel Diseases | Tamás Resál Péter Bacsur Csilla Keresztes Anita Bálint Renáta Bor | 2023/8/5 |
An Analysis of the Content of Metalloproteinases in the Intestinal Wall of Patients with Crohn’s Disease | Life | Grzegorz Chrzanowski Grzegorz Pasternak David Aebisher Klaudia Dynarowicz Angelika Myśliwiec | 2023/10/5 |
Real-world effectiveness and safety of vedolizumab induction therapy for ulcerative colitis: A prospective nationwide Polish observational study | Advances in Clinical and Experimental Medicine | Edyta Zagórowicz Halina Cichoż-Lach Maria Kopertowska-Majchrzak Piotr Eder Kamila Stawczyk-Eder | 2024 |
Effect of Nigella sativa on Selected Gastrointestinal Diseases | Sara Jarmakiewicz-Czaja Magdalena Zielińska Kacper Helma Aneta Sokal Rafał Filip | 2023/4/3 | |
Type B aortic dissection atypically presenting as chronic abdominal pain | Gastroenterology Review/Przegląd Gastroenterologiczny | Rafał Filip Wiesław Guz | 2023/7/27 |
S1063 Improvement in Inflammatory Biomarker Levels Through Week 12 in Moderately to Severely Active Ulcerative Colitis Patients Treated With Guselkumab: Results From the Phase … | Official journal of the American College of Gastroenterology| ACG | Tadakazu Hisamatsu Laurent Peyrin-Biroulet Axel Dignass Kuan-Hsiang G Huang Matthew Germinaro | 2023/10/1 |
What Do NAFLD, Liver Fibrosis, and Inflammatory Bowel Disease Have in Common? Review of the Current Literature | Sara Jarmakiewicz-Czaja Jolanta Gruszecka Rafał Filip | 2023/3/3 | |
The Role of Genetic and Epigenetic Regulation in Intestinal Fibrosis in Inflammatory Bowel Disease: A Descending Process or a Programmed Consequence? | Sara Jarmakiewicz-Czaja Aneta Sokal Katarzyna Ferenc Elżbieta Motyka Kacper Helma | 2023/5/27 |
